Revenue
$645.5m
-1.0% ↓ vs $652.1m
Pre-lease free cash flow fell to NZ$-62.3m and debtor days hit an unprecedented 61.9, undercutting the headline operating-profit recovery.
Revenue context before the current result.
Operating profit margin across covered periods.
Operating cash flow across covered periods.
Operating working-capital absorption or release by reporting period.
Key metrics
HY22 vs HY21
Revenue
$645.5m
-1.0% ↓ vs $652.1m
Net profit after tax
$2.9m
-14.7% ↓ vs $3.4m
Net cash inflow from operating activities
−$31m
Suppressed: metric quality flags mark this value as unsuitable for normal comparison.
Declared dividend per share
—
— vs 6.0c
Operating profit
$15m
+37.8% ↑ vs $10.9m
Profit before tax
$7.8m
+52.9% ↑ vs $5.1m
Cash and cash equivalents
$68.3m
-19.6% ↓ vs $85m
Total assets
$1.2b
+4.6% ↑ vs $1.2b
What changed
Trade debtors rose 12.8% to NZ$219.7m, pushing debtor days to 61.9 — unprecedented against the supplied historical range of 52.6–54.4 days (mean 53.3). With capex nearly doubling to NZ$31.3m, pre-lease free cash flow landed at -NZ$62.3m, below the historical baseline range (mean -NZ$9.3m) and a NZ$83.3m reversal from HY21's +NZ$20.9m.
Reported operating performance moved in the opposite direction. Revenue eased 1.0% to NZ$645.5m, operating profit rose to NZ$15.0m, and PBT grew 52.9% to NZ$7.8m. Attributable NPAT, however, fell 14.7% to NZ$2.9m because minority interests took NZ$2.8m of the NZ$5.7m continuing-operations profit. Net debt rose to NZ$120.6m and no interim dividend was declared (HY21: 6.0c).
What matters
PBT grew 52.9% while OCF turned negative — the cash conversion deterioration is the central read on this result. Even though the supplied baseline classifies the NZ$18.1m operating working-capital build as within normal range, debtor days at 61.9 are unprecedented in the four-period history, so receivable timing rather than aggregate working capital is the pressure point. Until cash collection normalises, the operating-profit recovery is not yet translating into shareholder value.
Capital intensity has stepped up sharply. Capex of NZ$31.3m equals 4.9% of revenue versus 2.4% prior, and combined with the operating-cash swing produced the below-normal pre-lease FCF outcome. This matters because the cash gap was funded from the balance sheet rather than earnings.
The attributable NPAT decline is structural, not tax-driven. The effective tax rate was -26.3% (a tax benefit) versus +32.7% prior, so tax helped — not hurt — NPAT. The decline came from minority interests claiming NZ$2.8m of continuing-operations profit. PBT, at +52.9%, is the cleaner operating read.
Expectations
The HY21/FY21 shape shows the first half historically contributing 47.8% of revenue and only 38.5% of NPAT, so the business is second-half weighted and HY22's softer revenue base annualises to roughly NZ$1.29bn — below FY21's NZ$1.37bn unless H2 outperforms.
Against that shape, the second half must absorb a meaningful cash recovery: -NZ$62.3m of pre-lease FCF in H1 is materially below the historical mean (-NZ$9.3m), and FY21 generated only NZ$18.6m of implied H2 operating cash flow on its own. The release does not quantify when receivables are expected to convert or whether the capex step-up continues, leaving the H2 cash outlook unsupported by disclosure.
Quality of result
None of those gains depend on tax or one-offs. However, the Other segment loss widened to -NZ$19.8m from -NZ$11.6m, partly offsetting segment progress.
The earnings quality concern sits below the P&L. With OCF at -NZ$31.0m against attributable NPAT of NZ$2.9m, FCF-to-NPAT is -2,129% — the result was effectively cash-funded by the balance sheet, with NZ$25.0m of additional receivables and a NZ$8.4m drawdown of cash reserves. Gross borrowings actually declined slightly to NZ$188.9m, but cash fell NZ$16.7m, so the funding came from cash buffer rather than new debt. The decision to omit an interim dividend (HY21 paid 6.0c) is consistent with that cash strain and signals management caution rather than confidence in near-term conversion.
Unresolved
This briefing cannot assess the underlying credit quality of the receivables, the contracted shape of forward apple-season volumes, or the durability of the H1 segment-result improvements.
Chat
Ask follow-up questions about T&G Global Limited and subsidiary companies's HY22 result.
Informational only. No buy, sell, hold, price-target, or personal financial advice.
Informational only. No buy, sell, hold, price-target, or personal financial advice.
Open to load segment breakdown.
Open to load analytical metrics.
Open to load key metrics.
2022 Half Year Results Announcement
HY22 / results announcement2022 Half Year Results Media Statement
HY22 / results release2022 Interim Report
HY22 / financial reportNZX Financial Results Announcement June 2021
HY21 / results announcementNZX Financial Results Announcement June 2021
HY21 / results releaseNZX Interim Report June 2021
HY21 / financial reportT&G Annual Report 2021
FY21 / financial reportT&G Media Release Financial Year 2021
FY21 / media releaseT&G Results Announcement 2021
FY21 / results announcementRelated insights
Cross-company views selected from the metrics in this briefing.
Earnings quality and statutory distortions
PBT and NPAT growth diverged by 67.6pp.
Revenue growth context
Revenue growth was -1.0% for this reporting period.
ROE and capital efficiency
ROE was 0.5%, -0.2pp versus the prior comparable period.
Working-capital pressure
Inventory days were 52 days, -1 days versus the prior comparable period.
Get the next T&G Global Limited and subsidiary companies briefing and related NZX reporting-season updates by email.